Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

U.S. Treasury: Chinese Tariffs On Hold, Pre-Markets Gain

Published 05/20/2018, 10:08 PM
Updated 07/09/2023, 06:31 AM
US500
-
DJI
-
BA
-
MCD
-
AAPL
-
NKE
-

Monday, May 21, 2018

Market futures are generously in the green in the first pre-market trading day of the week, even with no major national economic data or quarterly earnings reports from marquee names on the S&P 500. Yet talk over this past weekend from U.S. Treasury Secretary Steven Mnuchin — that offsetting tariffs between the U.S. and China are being put on hold — looks to have generated a pleasant sigh of relief from traders early today.

In fact, Mnuchin said the tariff dispute was never a “trade war,” as some have glibly named it — it’s only ever been a “trade dispute.” And, for now, both sides have decided to postpone enacting tariffs on each other’s goods, which removes one dark cloud from the economic landscape, at least in the present. U.S. farmers, as well as American companies that do lots of business in China, like Apple (NASDAQ:AAPL) , Boeing (NYSE:BA) , Nike (NYSE:NKE) and McDonalds (NYSE:MCD) , all look toward a near-term benefit in share prices.

At this hour, we are seeing implied opens on our main indexes in solid green territory: the Dow has an implied open of +230, the Nasdaq +50 and the S&P 500 +15. That said, with a real dearth of economic indicators for the rest of the day — indeed, we don’t even get the latest PMI data (Manufacturing and Services) until Wednesday of this week — any further news on this front or elsewhere may have an opportunity to shift investor focus one direction or the other. Should Mnuchin’s comforting words remain the principle narrative today, we don’t really see much drag on current index valuations.

This morning’s Chicago Fed National Activity Index (CFNAI) report for April was released this morning, with a slight beat sequentially and higher than expectations. Growth of 0.34% eked out a narrow margin over March’s 0.32%, whereas analyst had been looking for 0.25%. The index is a survey taking into account 85 separate national indicators concerning things like production, employment and consumption. As such, it is an economic metric like many others we track, and again we see modest growth without much strain from inflation.

We hope the newsworthiness of market activity picks up this week, in order to better serve our readers in making sound investment decisions. in the meantime, please check out Zacks Chief Strategist John Blank’s latest Global Week Ahead article: More Populism and More Inexperience

Mark Vickery
Senior Editor

Questions or comments about this article and/or its author? Click here>>
https://www.zacks.com/bio/mark-vickery

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


The Boeing Company (BA): Free Stock Analysis Report

Apple Inc. (AAPL): Free Stock Analysis Report

McDonald's Corporation (MCD): Free Stock Analysis Report

NIKE, Inc. (NKE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.